Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Harman

Showing results (221-230 of 232) with videos related to

Pageof 24
Sort By:
Obstetrics and Gynecology|May 2, 2015
The North American Fetal Therapy Network Consensus Statement: prenatal management of uncomplicated monochorionic gestationsStephen P Emery, Mert Ozan Bahtiyar, Jodi S Dashe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2004
Determinants of outcome in melanoma patients with cerebral metastasesK M Fife, M H Colman, G N Stevens, et al.
American Journal of Obstetrics and Gynecology|January 15, 2008
Predictors of necrotizing enterocolitis in preterm growth-restricted neonatesAnita C Manogura, Ozhan Turan, Michelle L Kush, et al.
Nature Communications|June 28, 2019
DOT1L inhibition reveals a distinct subset of enhancers dependent on H3K79 methylationLaura Godfrey, Nicholas T Crump, Ross Thorne, et al.
Plos One|September 26, 2015
Genetic Variation in the Platelet Endothelial Aggregation Receptor 1 Gene Results in Endothelial DysfunctionAdam S Fisch, Laura M Yerges-Armstrong, Joshua D Backman, et al.
Nature Communications|February 10, 2022
Dynamic Runx1 chromatin boundaries affect gene expression in hematopoietic developmentDominic D G Owens, Giorgio Anselmi, A Marieke Oudelaar, et al.
Obstetrics and Gynecology|February 3, 2007
Predictors of neonatal outcome in early-onset placental dysfunctionAhmet A Baschat, Erich Cosmi, Catarina M Bilardo, et al.
Oncogene|January 29, 2022
Potent, p53-independent induction of NOXA sensitizes MLL-rearranged B-cell acute lymphoblastic leukemia cells to venetoclaxKlaudyna Fidyt, Agata Pastorczak, Julia Cyran, et al.
Leukemia|April 4, 2020
H3K79me2/3 controls enhancer-promoter interactions and activation of the pan-cancer stem cell marker PROM1/CD133 in MLL-AF4 leukemia cellsLaura Godfrey, Nicholas T Crump, Sorcha O'Byrne, et al.
Cell Reports|December 15, 2021
The onset of circulation triggers a metabolic switch required for endothelial to hematopoietic transitionEmanuele Azzoni, Vincent Frontera, Giorgio Anselmi, et al.
Pageof 24

Showing results (221-230 of 232) with videos related to

Sort By:
Pageof 24
Obstetrics and Gynecology|May 2, 2015
The North American Fetal Therapy Network Consensus Statement: prenatal management of uncomplicated monochorionic gestationsStephen P Emery, Mert Ozan Bahtiyar, Jodi S Dashe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2004
Determinants of outcome in melanoma patients with cerebral metastasesK M Fife, M H Colman, G N Stevens, et al.
American Journal of Obstetrics and Gynecology|January 15, 2008
Predictors of necrotizing enterocolitis in preterm growth-restricted neonatesAnita C Manogura, Ozhan Turan, Michelle L Kush, et al.
Nature Communications|June 28, 2019
DOT1L inhibition reveals a distinct subset of enhancers dependent on H3K79 methylationLaura Godfrey, Nicholas T Crump, Ross Thorne, et al.
Plos One|September 26, 2015
Genetic Variation in the Platelet Endothelial Aggregation Receptor 1 Gene Results in Endothelial DysfunctionAdam S Fisch, Laura M Yerges-Armstrong, Joshua D Backman, et al.
Nature Communications|February 10, 2022
Dynamic Runx1 chromatin boundaries affect gene expression in hematopoietic developmentDominic D G Owens, Giorgio Anselmi, A Marieke Oudelaar, et al.
Obstetrics and Gynecology|February 3, 2007
Predictors of neonatal outcome in early-onset placental dysfunctionAhmet A Baschat, Erich Cosmi, Catarina M Bilardo, et al.
Oncogene|January 29, 2022
Potent, p53-independent induction of NOXA sensitizes MLL-rearranged B-cell acute lymphoblastic leukemia cells to venetoclaxKlaudyna Fidyt, Agata Pastorczak, Julia Cyran, et al.
Leukemia|April 4, 2020
H3K79me2/3 controls enhancer-promoter interactions and activation of the pan-cancer stem cell marker PROM1/CD133 in MLL-AF4 leukemia cellsLaura Godfrey, Nicholas T Crump, Sorcha O'Byrne, et al.
Cell Reports|December 15, 2021
The onset of circulation triggers a metabolic switch required for endothelial to hematopoietic transitionEmanuele Azzoni, Vincent Frontera, Giorgio Anselmi, et al.
Pageof 24